Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
89.44
+0.78 (0.88%)
Dec 20, 2024, 2:30 PM EST - Market open
Boston Scientific Revenue by Segment
History
| Date | Cardiology | Endoscopy | Peripheral Interventions | Urology | Neuromodulation | Specialty Pharma |
|---|---|---|---|---|---|---|
| Sep 30, 2024 | 7.80B | 2.64B | 2.30B | 2.10B | 1.08B | - |
| Jun 30, 2024 | 7.32B | 2.59B | 2.23B | 2.05B | 1.04B | - |
| Mar 31, 2024 | 6.97B | 2.55B | 2.18B | 2.01B | 998.00M | - |
| Dec 31, 2023 | 6.71B | 2.48B | 2.11B | 1.96B | 976.00M | - |
| Sep 30, 2023 | 6.49B | 2.41B | 2.05B | 1.91B | 956.00M | - |
| Jun 30, 2023 | 6.32B | 2.34B | 1.99B | 1.86B | 948.00M | - |
| Mar 31, 2023 | 6.13B | 2.27B | 1.94B | 1.83B | 943.00M | - |
| Dec 31, 2022 | 5.93B | 2.22B | 1.90B | 1.77B | 918.00M | - |
| Sep 30, 2022 | 5.83B | 2.21B | 1.88B | 1.74B | 913.00M | - |
| Jun 30, 2022 | 5.69B | 2.18B | 1.86B | 1.69B | 913.00M | - |
| Mar 31, 2022 | 5.58B | 2.17B | 1.85B | 1.64B | 921.00M | - |
| Dec 31, 2021 | 5.42B | 2.14B | 1.82B | 1.58B | 910.00M | - |
| Sep 30, 2021 | 5.12B | 2.10B | 1.79B | 1.52B | 898.00M | - |
| Jun 30, 2021 | 4.91B | 2.04B | 1.75B | 1.48B | 893.00M | - |
| Mar 31, 2021 | 4.39B | 1.84B | 1.62B | 1.32B | 768.00M | 191.00M |
| Dec 31, 2020 | 4.29B | 1.78B | 1.58B | 1.29B | 761.00M | 219.00M |
| Sep 30, 2020 | 4.47B | 1.76B | 1.55B | 1.29B | 790.00M | 241.00M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.